Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;55(6):782-789.
doi: 10.1097/SHK.0000000000001673.

Toward Monocyte HLA-DR Bedside Monitoring: A Proof-of-Concept Study

Pénélope Bourgoin  1   2 , Ramazan Taspinar  3 , Morgane Gossez  3 , Fabienne Venet  3 , Benjamin Delwarde  4 , Thomas Rimmelé  4 , Pierre-Emmanuel Morange  2 , Fabrice Malergue  1 , Guillaume Monneret  3
Affiliations

Toward Monocyte HLA-DR Bedside Monitoring: A Proof-of-Concept Study

Pénélope Bourgoin et al. Shock. .

Abstract

Objectives: Decreased expression of human leukocyte antigen-DR on monocytes (mHLA-DR) is recognized as the most appropriate marker for the monitoring of immune alterations in septic patients and critically ill subjects. Its measurement has been established for years by flow cytometry, but remains under-used due to pre-analytical constraints. The objectives of the present work were to develop a rapid and robust one-step protocol.

Methods: A novel, simplified protocol has been developed to measure mHLA-DR in whole blood using flow cytometry. It is a one-step procedure that includes red cell lysis, antibodies, and fixative reagents. It has been compared to the standardized routine protocol in two consecutive cohorts of septic shock patients (n = 37). Finally, the protocol was applied to a few subjects in point-of-care settings, by collecting capillary blood from fingerpricks.

Results: Strong correlation was observed between the one-step method and routine protocol in 24 patients. After testing several stabilizing agents, the procedure was further optimized by adding a low-dose formaldehyde to the stain and lyse solution. This improved method was tested in a second cohort of 13 patients, and again strongly correlated to the routine protocol. Finally, the fingerprick and venous puncture samples were shown to provide similar results.

Conclusions: The present work demonstrates the feasibility of a bedside protocol for flow cytometry measurement of mHLA-DR in critically ill subjects. This helps overcome pre-analytical constraints previously identified, which have limited wider use of this biomarker in intensive care units. In addition, preliminary results from fingerprick samples are promising.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

References

    1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 395 (10219):200–211, 2020.
    1. Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority — a WHO resolution. N Engl J Med 377 (5):414–417, 2017.
    1. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13 (12):862–874, 2013.
    1. Hotchkiss RS, Opal SM. Activating immunity to fight a foe — a new path. N Engl J Med 382 (13):1270–1272, 2020.
    1. Monneret G, Gossez M, Aghaeepour N, Gaudilliere B, Venet F. How clinical flow cytometry rebooted sepsis immunology. Cytometry A 95 (4):431–441, 2019.

Publication types